INS and metabolic syndrome: Serum ADI concentrations, an adipocytokine-related insulin sensitivity, were markedly lower in MetS individuals than in non-MetS individuals and healthy controls (P < 0.05 or P < 0.01; Table 1 and Figure 1(b)).